On Tuesday, Delaware’s highest court said it will hear an appeal by GSK and other drugmakers seeking to end more […]
Delaware Top Court Will Hear Drugmakers’ Appeal To End Zantac Lawsuits Read More »
On Tuesday, Eli Lilly (NYSE: LLY) said it has begun selling vials of the lowest starter dose of its popular
On Monday, McKesson (NYSE: MCK), a drug distributor, said it would buy a controlling stake in community cancer center Florida
On Saturday, Novartis (NYSE: NVS), a Swiss drugmaker, said it had received a binding offer from Germany’s Siemens Healthineers to
Eli Lilly’s (NYSE: LLY) treatment for early Alzheimer’s is expected to be blocked for use by Britain’s National Health Service
NHS Likely to Block Eli Lilly (NYSE: LLY) Alzheimer’s Treatment, The Telegraph Reports Read More »
NEW YORK – Now that the U.S. government has negotiated prices for some Medicare program drugs effective in 2026, Wall
Analysis: Ozempic on Wall Street’s List for 2027 Medicare Drug Negotiations Read More »
AstraZeneca (NASDAQ: AZN) has warned it could relocate its vaccine manufacturing site from the UK to the United States as
AstraZeneca Threatens UK Vaccine Exit Over Deadlocked State Aid Talks, FT Reports Read More »
On Thursday, the U.S. Food and Drug Administration approved updated COVID-19 vaccines made by Pfizer (NYSE: PFE) and Moderna (NASDAQ:
FDA Greenlights Updated COVID Vaccines to Combat New Variants Ahead of Fall Campaign Read More »
Alzheimer’s patients in Britain’s state-run health service are unlikely to get access to Eisai and Biogen’s new Leqembi drug after
UK State Health Service Declares New Alzheimer’s Drug Too Expensive for Widespread Use Read More »
Copyright © 2024 abbonews.com
